Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 52 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 165 | 9,253−2.3%/yr | −2.3%/yr | 7.11.0× | 8% | 9,520 in 2030+0.5%/yr |
| Tumor & fibroid embolization |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 14 |
| 674+3.6%/yr |
| +3.6%/yr |
| 0.50.9× |
| 49% |
| 1,750 in 2030+17%/yr |
| Tumor ablation | 2 | 357+0.9%/yr | +0.9%/yr | 0.30.8× | 0% | 740 in 2030+13%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.